They showed that reduced EpCAM expression was associated with aggressive features in mucoepidermoid carcinoma, whereas adenocystic carcinoma (AdCC) showed negative or weakly positive EpCAM immunoreactivity. Here, EPCAM is linked to adenoid cystic carcinoma.